Latest News

HS Foundation’s HS CAPE (Community Awareness and Patient Empowerment) Program Request for Proposals

April 20, 2021

The goal of the CAPE grant is to stimulate the development of programs that increase disease awareness, provide support to patients and caregivers, improve patient care or benefit patients with HS in other ways. Typical awards will be for up to $2,000 (costs of the program only). We hope you will consider applying!
Read more


Clinical Epidemiology and Management of Hidradenitis Suppurativa

April 1, 2021

Understanding hidradenitis suppurativa clinical epidemiology and management facilitates early diagnosis and treatment, thereby reducing morbidity with the potential to favorably alter disease trajectory.
Read more




Comorbidity screening in hidradenitis suppurativa

January 22, 2021

Systematic reviews were performed to summarize evidence on the prevalence and incidence of 30 comorbidities in patients with HS relative to the general population.
Read more


COVID-19 Vaccines: Information for People with HS & their Caregivers

December 19, 2020

We know that you and your family probably have many questions about the COVID-19 vaccines that are being approved by the U.S. Food and Drug Administration (FDA). We are here to help and provide you with the most current information.
Read more


Hidradenitis Suppurativa Foundation Danby Research Grants

June 7, 2020

For the past four years, the Hidradenitis Suppurativa Foundation (HSF) has proudly sponsored up to $10,000 for research projects that will have a sustained, powerful influence on our understanding of hidradenitis suppurativa (HS).
Read more


Are people are willing to use teledermatology for Hidradenitis Suppurativa care?

June 5, 2020

In new, yet unpublished data from a project by Joslyn Kirby, Ashley Eichelberger, Melissa Butt, Colleen Silva, and Aretha Mosley of Penn State Hershey School of Medicine, patients shared their thoughts and experience about long-distance dermatology visits.
Read more


The Hidden, Common Disease You've Never Heard Of

June 2, 2020

In today’s informed and connected world, it’s hard to believe there might be common diseases that you have never heard of.
Read more


6 Myths about Hidradenitis Suppurativa

June 1, 2020

We addressed 6 myths about Hidradenitis Suppurativa
Read more



What is the right dose of infliximab for Hidradenitis Suppurativa?

April 20, 2020

Infliximab is an intravenous (IV) medication that can help Hidradenitis Suppurativa (HS). The dose and timing of infliximab vary. The authors determined which dose was the best when starting treatment for HS.
Read more


Global Registry for Hidradenitis Suppurativa + COVID-19

April 17, 2020

International HS experts have recently established the Global HS COVID-19 Registry to better understand the risk of infection and clinical course of HS patients in the setting of COVID-19.
Read more


Frequently Asked Questions about Hidradenitis Suppurativa (HS) and COVID-19

April 6, 2020

What is COVID-19, and how is it different from the flu or other infections we have dealt with?
Read more


COVID-19 & Hidradenitis Suppurativa Podcast

March 24, 2020

HSF partnered with LearnSkin on a special podcast episode to bring expert insight into what COVID-19 means for dermatologists and their patients with Hidradenitis Suppurativa.
Read more


Plastic Surgical Management of Hidradenitis Suppurativa

March 10, 2020

Successful treatment of hidradenitis suppurativa requires a multidisciplinary team approach and multimodal therapy.
Read more


New drug shows promise for Hidradenitis Suppurativa treatment

February 27, 2020

An early study for bermekimab shows improvement in Hidradenitis Suppurativa (HS) activity and pain scores while demonstrating safety.
Read more


Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa

November 13, 2019

New findings, recently published in JAMA Dermatology, appear to show that having HS confers a modest risk of having a heart attack or a stroke.
Read more